Josie E. Parker

Acquired amphotericin B resistance attributed to a mutated <i>ERG3</i> in <i>Candidozyma auris</i>

Acquired Amphotericin B Resistance Attributed to a Mutated <i>ERG3</i> in <i>Candidozyma auris</i>

Exploring medium and long arm extensions of 1,2,4-triazole derivatives as <i>Candida albicans</i> 14α-demethylase (CYP51) inhibitors

A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1

The sterol C-24 methyltransferase encoding gene, erg6, is essential for viability of Aspergillus species

Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the <i>Mucor</i> species complex

Deletion of the Candida albicans TLO gene family results in alterations in membrane sterol composition and fluconazole tolerance

Genetic interaction analysis of <i>Candida glabrata</i> transcription factors <i>CST6</i> and <i>UPC2A</i> in the regulation of respiration and fluconazole susceptibility

Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in <i>ERG2</i> as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr

Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the <i>Mucor</i> species complex

The sterol C-24 methyltransferase encoding gene, <i>erg6</i> , is essential for viability of <i>Aspergillus</i> species

Cytochrome P450 168A1 from Pseudomonas aeruginosa is involved in the hydroxylation of biologically relevant fatty acids

Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

Loss-of-Function <i>ROX1</i> Mutations Suppress the Fluconazole Susceptibility of <i>upc2A</i> Δ Mutation in Candida glabrata, Implicating Additional Positive Regulators of Ergosterol Biosynthesis

Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure

Insights in the molecular mechanisms of an azole stress adapted laboratory-generated <i>Aspergillus fumigatus</i> strain

<i>In vivo</i> emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in <i>Candida auris</i>

Loss-of-function <i>ROX1</i> mutations suppress the fluconazole susceptibility of <i>upc2A</i> Δ mutation in <i>Candida glabrata</i> , implicating additional positive regulators of ergosterol biosynthesis

Mutations in <i>TAC1B</i> : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus

Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis

Small‐Molecule Inhibitors Targeting Sterol 14α‐Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against <i>Candida albicans</i>

Erratum for Kannan et al., “Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae <i>”</i>

Mutations in <i>TAC1B</i> : a novel genetic determinant of clinical fluconazole resistance in <i>C. auris</i>

Mutations in <i>hmg1</i> , Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus

Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae

The Evolution of Azole Resistance in <i>Candida albicans</i> Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions

Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens

Comparative genomics for the elucidation of multidrug resistance (MDR) in <i>Candida lusitaniae</i>